LIQUIDIA CORP (LQDA)

US53635D2027 - Common Stock

10.025  -0.24 (-2.39%)

After market: 10.34 +0.31 (+3.14%)

Full profile views are only available for registered users, you can see which data is available below.

Examples of complete profiles are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional data.

LIQUIDIA CORP

NASDAQ:LQDA (11/14/2024, 8:00:00 PM)

After market: 10.34 +0.31 (+3.14%)

10.025

-0.24 (-2.39%)

Chartmill TA Rating
Chartmill Setup Rating
Sector
GICS SectorHealth Care
GICS IndustryPharmaceuticals
GICS SubIndustry
Chartmill FA Rating
Valuation
Growth
Profitability
Health
Dividend
Chartmill High Growth Momentum
EPS Q2Q%
Sales Q2Q%
CRS
6 Month-21.13%
Overview
Earnings (Last)
Earnings (Next)
Ins Owners
Inst Owners
Market Cap842.10M
Shares
PEN/A
Fwd PEN/A
Dividend YieldN/A
Analysts
IPO
Stock Screener Links
Screen Image

Nasdaq Stock Screener

Find more stocks on Nasdaq

Screen Image

USA Stock Screener

Find more stocks on the USA

Screen Image

GICS Sector Stock Screener

Find competitors from the same sector on the USA

Screen Image

GICS Industry Stock Screener

Find competitors from the same industry on the USA

Screen Image

Technical Stock Screener

Find stocks with similar TA and Setup ratings on the USA

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Best Technical Competitors Stock Screener

Find the competitors with the best technical ratings on the USA

Screen Image

Best Technical Setups Competitors Stock Screener

Find the competitors with the best technical and setup ratings on the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA

Screen Image

Best Analyst Rating Competitors Stock Screener

Find the competitors with the best analyst ratings on the USA

LQDA Daily chart

Company Profile

Liquidia Corp. operates as a holding company which through its subsidiary engages in developing and commercializing biopharmaceutical products. The company is headquartered in Morrisville, North Carolina and currently employs 136 full-time employees. The company went IPO on 2018-07-26. The firm is focused on the development, manufacture and commercialization of products that address unmet patient needs, with a focus directed towards rare cardiopulmonary diseases, such as pulmonaryarterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD). The firm operates through its wholly owned operating subsidiaries, Liquidia Technologies, Inc. and Liquidia PAH, LLC. Its proprietary PRINT technology is a particle engineering platform, which enable precise production of uniform drug particles. Its lead product candidate is YUTREPIA for the treatment of PAH and PH-ILD. YUTREPIA is an inhaled dry powder formulation of treprostinil designed with PRINT to improve the therapeutic profile of treprostinil by enhancing deep lung delivery while using a convenient, dry-powder inhaler (DPI) and by achieving higher dose levels than the labeled doses of current inhaled therapies.

Company Info

LIQUIDIA CORP

419 Davis Drive, Suite 100

Morrisville NORTH CAROLINA 27560

P: 19193284400

CEO: Neal Fowler

Employees: 136

Website: https://www.liquidia.com/

LQDA News

News Image2 days ago - Liquidia CorporationLiquidia Corporation Reports Third Quarter 2024 Financial Results and Provides Corporate Update
News Image2 days ago - Liquidia CorporationLiquidia Corporation Reports Third Quarter 2024 Financial Results and Provides Corporate Update

Liquidia Corporation (LQDA) today reported financial results for the third quarter ended September 30, 2024....

News Image3 days ago - Liquidia CorporationLiquidia to Present at the Stifel 2024 Healthcare Conference
News Image3 days ago - Liquidia CorporationLiquidia to Present at the Stifel 2024 Healthcare Conference

Liquidia Corporation (LQDA) to present at the Stifel 2024 Healthcare Conference in New York City on Tuesday, November 19, 2024, from 3:00 – 3:30 p.m. ET. ...

News Image9 days ago - Liquidia CorporationLiquidia Corporation to Report Third Quarter 2024 Financial Results on November 13, 2024
News Image11 days ago - Liquidia CorporationLiquidia Corporation to Report Third Quarter 2024 Financial Results on November 11, 2024

LQDA Twits

Here you can normally see the latest stock twits on LQDA, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.

Example Twits:

Twits example